28.09.2016 Views

Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 - 2022

The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players.

The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong> <strong>by</strong><br />

<strong>Type</strong>, <strong>End</strong>-<strong>user</strong> & <strong>Geography</strong>, <strong>2016</strong> – <strong>2022</strong>


P e r s i s t e n c e M a r k e t R e s e a r c h<br />

About Us<br />

Persistence <strong>Market</strong> Research (PMR) is a market intelligence company, providing global business information<br />

reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking<br />

insight for thousands of decision makers. We have an experienced team of Analysts, Researchers,<br />

and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze<br />

information. Our business offerings represent the latest and the most reliable information indispensable for<br />

businesses to sustain a competitive edge.<br />

Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical,<br />

energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports<br />

provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified<br />

research methodology, our syndicated reports strive to serve clients and satisfy their overall research<br />

requirement.<br />

Copyright © 2015 Persistence <strong>Market</strong> Research<br />

All Rights Reserved. This document contains highly confidential information and is the sole property of PMR.<br />

No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of PMR.<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |


P e r s i s t e n c e M a r k e t R e s e a r c h<br />

Report Media Releases<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong> <strong>by</strong> <strong>Type</strong>, <strong>End</strong>-<strong>user</strong> &<br />

<strong>Geography</strong>, <strong>2016</strong> - <strong>2022</strong><br />

<strong>Irritable</strong> bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized <strong>by</strong> colon muscle<br />

contractions. <strong>Irritable</strong> bowel syndrome affects the large intestine. <strong>Irritable</strong> bowel syndrome is associated with<br />

malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration<br />

and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood<br />

test and endoscopy are normally performed to detect this syndrome. <strong>Irritable</strong> bowel syndrome is a common disorder.<br />

There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in<br />

decreasing the symptoms.<br />

Request to view TOC : http://www.persistencemarketresearch.com/toc/9938<br />

The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined<br />

diagnosis criteria and exploration of novel therapeutic classes <strong>by</strong> the key market players. Additionally, change in lifestyle<br />

and eating habits increases the incidence of this disorder that may escalate the use of this treatment and hence drive<br />

the market growth. However, lack of specific treatment which treat all the symptoms of this disorder may restrain the<br />

growth of this market. In addition, higher competition among the key players in terms of pricing is anticipated to hamper<br />

overall growth of this market.<br />

<strong>Irritable</strong> bowel syndrome market is classified on the basis of type, end <strong>user</strong> and geography.<br />

Based on the type, the global irritable bowel syndrome market is segmented into the following:<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with Constipation<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with Diarrhea<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with alternating Constipationand Diarrhea<br />

Based on the end <strong>user</strong>, the global <strong>Irritable</strong> bowel syndrome market is segmented into the following:<br />

Hospitals<br />

Clinics<br />

Homecare settings<br />

Depending on geographic regions, global irritable bowel syndrome treatment market is segmented into five key regions:<br />

North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically, North America dominates<br />

the global irritable bowel syndrome treatment market. High degree of therapeutic needs and penetration of generic<br />

drugs in North American market is anticipated to drive the growth of this market. Meanwhile, Europe is considered as<br />

the second largest market owing to the large patient population undergoing diagnosis of irritable bowel syndrome<br />

coupled with the increasing demand for treatment. Launch of novel drugs with improved efficacy which provide<br />

sustained relief from irritable bowel syndrome in APAC region primarily drives the growth of this market. In addition,<br />

growing awareness regarding chronic nature of irritable bowel syndrome among the people will further drive the growth<br />

of this market in APAC region.<br />

Increased awareness about available treatment among the patients, medical community is one of the major driver in<br />

global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population,<br />

increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and<br />

increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the<br />

forecast period.<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |


P e r s i s t e n c e M a r k e t R e s e a r c h<br />

Various key players dominating the global irritable bowel syndrome treatment market comprise Valeant<br />

Pharmaceuticals International Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, Lexicon Pharmaceuticals,<br />

Salix Pharmaceuticals, Ironwood Pharmaceuticals, Inc., and GlaxoSmithKline plc. Allergan Plc. among others.<br />

The report covers exhaustive analysis on:<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Segments<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Dynamics<br />

Historical Actual <strong>Market</strong> Size, 2013 - 2015<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Size & Forecast <strong>2016</strong> to <strong>2022</strong><br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> Current Trends/Issues/Challenges<br />

Competition & Companies involved<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> Drivers and Restraints<br />

Regional analysis includes<br />

North America<br />

Latin America<br />

Europe<br />

Asia Pacific<br />

Middle East & Africa<br />

Request to view Sample Report : http://www.persistencemarketresearch.com/samples/9938<br />

Report Highlights:<br />

Shifting Industry dynamics<br />

In-depth market segmentation<br />

Historical, current and projected industry size Recent industry trends<br />

Key Competition landscape<br />

Strategies of key players and product offerings<br />

Potential and niche segments/regions exhibiting promising growth<br />

A neutral perspective towards market performance<br />

For information regarding permissions, contact:<br />

Persistence <strong>Market</strong> Research<br />

90 Sate Street, Suite 700 Albany, NY 12207<br />

Tel: +1-518-618-1030<br />

Email: sales@persistencemarketresearch.com<br />

Website: http://www.persistencemarketresearch.com/<br />

media@persistencemarketresearch.com<br />

<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!